Zogenix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Zogenix and buy or sell other stocks, ETFs, and their options commission-free!

About ZGNX

Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. 

CEO
Iris Löw-Friedrich, MD, PhD
CEOIris Löw-Friedrich, MD, PhD
Employees
Employees
Headquarters
Emeryville, California
HeadquartersEmeryville, California
Founded
2006
Founded2006
Employees
Employees

ZGNX Key Statistics

Market cap
1.50B
Market cap1.50B
Price-Earnings ratio
-6.55
Price-Earnings ratio-6.55
Dividend yield
Dividend yield
Average volume
3.46M
Average volume3.46M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$26.90
52 Week high$26.90
52 Week low
$11.03
52 Week low$11.03

People also own

Based on the portfolios of people who own ZGNX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.